As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is co-founder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company.
XPRIZE FOUNDATION
XPRIZE Is Solving The World’s Grand Challenges Through Incentive Prize Competitions
SINGULARITY UNIVERSITY
SU Teaches Leaders To Leverage Exponential Tech To Solve Global Problems
COVAXX
COVAXX's Mission: Defeating COVID-19
Celularity
Celularity’s Purpose Is To Harness The Power Of The Living Cell To Augment Biology, Immunity And Longevity
FOUNTAIN LIFE
Fountain Life Is A Ground-Breaking Longevity Company Developing A Data-Driven, Personalized Treatment Platform
HUMAN LONGEVITY, INC.
Human Longevity Uses Machine Learning To Develop New Ways To Fight Diseases Associated With Aging
FUTURELOOP
Futureloop Is Your Personal Machine Learning Engine, Trained To Source A Global Set Of Information
BOLD CAPITAL PARTNERS
Learn About Peter’s Breakthrough Investment Fund Targeting Exponential Companies
LIFEFORCE
A single, convenient solution that empowers you with everything you need to make the right health decisions at the right time.
Abundance360
Abundance360 is Peter Diamandis' year-round Mastermind and Executive program. It is Singularity University's highest-level program.
Insights in your inbox
The latest insights on exponential technologies and entrepreneurship delivered straight to your inbox.
